|Year : 2013 | Volume
| Issue : 3 | Page : 195-199
Phytochemical screening and cytotoxicity studies of Chrysophyllum pruniforme Pierre ex Engl. barks
Sophie Aboughe Angone1, L Mewono2, M Boukandou Mounanga1, S Medzegue3, HF Ella Mendene1, JG Mba Ndong1, JF Djoba Siawaya3, A Souza4
1 Pharmacopea and Traditional Medicine Institute, National Center of Technological and Scientific Research, Lambaréné, Gabon
2 Medical Research unit Albert Schweitzer Hospital, Lambaréné, Gabon
3 National Laboratory of Public Health, Libreville, Gabon
4 National Institute of Agronomy and Biotechnology, Franceville, Gabon
|Date of Submission||18-Sep-2012|
|Date of Acceptance||16-Nov-2012|
|Date of Web Publication||23-May-2013|
Sophie Aboughe Angone
Pharmacopea and Traditional Medicine Institute, National Center of Technological and Scientific Research, Po. Box: 1156, Libreville
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Chrysophyllum pruniforme of family sapotaceae is a plant used in traditional medicine in Gabon. Materials and Methods: In this study, C. pruniforme barks were subjected to phytochemical screening and cytotoxicity investigations. Different concentrations of aqueous and total phenolic extract were tested on mice and on human erythrocytes. Results: Phytochemical screening of C. pruniforme barks revealed the presence of flavonoids, saponins, and tannins, reducing sugars, polyphenols and traces of anthraquinones. When tested in vitro, aqueous and the phenolic extracts showed hemolytic activities on human erythrocytes with phenolic compounds being more cytotoxic than aqueous extracts. In vivo study of toxicity, allowed to determine the LD 50 at 90 mg/kg for the doses of 50, 150 and 250 mg/kg of body weight. Conclusion: These data indicate in one hand that C. pruniforme is rich in phenolic compounds and that the aqueous and total phenolic extracts could be considered as toxic for mice and maybe potentially toxic to humans in the other hand.
Keywords: Chrysophyllum, pruniforme , cytotoxicity polyphenols, phytochemical screening
|How to cite this article:|
Angone SA, Mewono L, Mounanga M B, Medzegue S, Ella Mendene H F, Mba Ndong J G, Djoba Siawaya J F, Souza A. Phytochemical screening and cytotoxicity studies of Chrysophyllum pruniforme Pierre ex Engl. barks. Phcog Res 2013;5:195-9
|How to cite this URL:|
Angone SA, Mewono L, Mounanga M B, Medzegue S, Ella Mendene H F, Mba Ndong J G, Djoba Siawaya J F, Souza A. Phytochemical screening and cytotoxicity studies of Chrysophyllum pruniforme Pierre ex Engl. barks. Phcog Res [serial online] 2013 [cited 2020 May 28];5:195-9. Available from: http://www.phcogres.com/text.asp?2013/5/3/195/112427
| Introduction|| |
In sub-Saharan Africa, traditional phytotherapy is an alternative to modern chemical- and industrial-based medicines and is widely used in rural and even urban areas. This is essentially due to the prohibitive cost of pharmaceutical-based medicine and the low incomes of a major part of the population. In addition, the efficacy of many of these traditional and plant-based medicines is proven. In Africa, for example the leaves of Trichilia emitica (Miliaceae), a plant used in traditional medicine in Mali, activated the complement system and induced the proliferation of T and B-lymphocytes.  In Asia and particularly in China and Japan, Bupleurum falcatum (Umbelliferae), a Sino-Japanese plant, has shown a biological activity on gastric diseases.  Ultimately, western and pharmaceutical-based medicines were initially developed from phyto-molecules and later, took advantage of applied and industrial chemistry. Either obtained from plant decoctions or after extensive purification of phytochemical compounds, plant-derived medicines have been proven to be effective in the prevention or treatment various infectious diseases (bacterial, fungal parasitic and viral infections) and non-infectious diseases. These secular treatments include body-washes, decoctions, massages, ingestions, etc. These local and traditional phytotherapies tend to be promoted by local and international organizations. However, the lack of valuable and complete knowledge on the nature and recipes of these medicines is one of the major concerns of local politics, physicians, and scientists. From a public health angle, it is crucial to gain knowledge on these plant-based medicines prepared and prescribed by practitioners, particularly in terms of toxicity, composition, specific efficacy on the disease and relay the findings to practitioners of this alternative medicine for the protection and the security of the patients. In this study, our objective was to investigate, in vitro (on erythrocytes) and in vivo (on mice), the effects of Chrysophyllum pruniforme [synonym: Donella pruniformis (Pierre ex Engl.)],  a sapotaceae plant widely spread from West to East Africa and Central Africa (from Uganda, Tanzania, Sierra Leone, Congo and Gabon), and often used by traditional practitioners. In Central Africa, particularly in Congo and Gabon, C. pruniforme bark infusion is used to heal coughs. In the present study, we have performed a phytochemical analysis C. pruniforme bark extract and we have evaluated the cytotoxicity of different extracted-fractions (water and ethanol fractions and polyphenol-enriched fraction) on human erythrocytes and on mice.
| Materials and Methods|| |
Plant identifications and barks collection
The botanical identification of C. pruniforme was carried out by botanical experts from the Gabonese National Herbarium (voucher number 1359 S.R.F). Bark collection was carried out after local authorities authorized our investigation protocol [Figure 1].
|Figure 1: Study design the investigations protocol Barks collection from Chrysophillum pruniforme|
Click here to view
Extraction of plant phytochemical compounds
Different mixtures of phytochemical compounds were independently extracted (100 grams per liter; 24 hours; room temperature) after vigorous stirring with water (fraction A) and 100% ethanol (fraction B). In addition, polyphenol-enriched fraction (fraction C) was extracted from 50 g of material (in 800 mL of 80% acetone; 24 hours; room temperature). Acetone solvent was removed by using a rotavapor. The remaining aqueous solution was successively washed twice with dichloromethane and with ethyl acetate (to remove flavonoids, the pellet containing polyphenols were frozen and lyophilized). 
Fraction A and B were subjected to chemical-based screening to determine their composition (secondary metabolites). Different tests were conducted in order to determine the chemical composition of each fraction.
Identification of saponins
1 gram of Fraction A and B each were collected separately, homogenized in 3 mL of water for 15 seconds, and stored at room temperature for 15 minutes. Occurrence and persistence of foam (more than 1 cm height) indicated the presence of saponins. 
1 gram of initial ground material was mixed with 2 mL of chloroform. The supernatant was collected and aqueous KOH at 10% (v/v) was added to the test tube. After agitation, occurrence of a reddish coloration indicated the presence of anthraquinones. 
Reaction to ferric chloride (FeCl 3 ) was used to reveal the presence of polyphenol. 2 mL of fraction A and B were prepared and mixed with 1-2 drops of ferric chloride (solubilized in 2% ethanol). Occurrence of a dark blue or green coloration indicated the presence of polyphenols. 
1.5 grams of initial ground material was mixed with 10 mL of methanol 80%, agitated for 15 minutes, and the soluble fraction was transferred into test tubes. Occurrence of tannins was tested by addition of FeCl 3 (1% in water). Occurrence of dark blue coloration indicated the presence of gallic tannins, whereas, brown green coloration indicated the presence of catechic tannins. 
2 mL of fraction A and B were prepared and mixed with 5 mL of Fehling's solutions (I and II) and boiled in a water bath for five minutes. Occurrence of a brick-red precipitate indicated the presence of free reducing sugars. 
Cytotoxicity on human erythrocytes
The cellular toxicity of C. pruniforme extracts was evaluated on blood samples from healthy donors. In whole blood or on erythrocytes clots, the degree of erythrocytes destruction can be used to evaluate the cytotoxicity of different fractions. We performed our assay as follows: Blood was collected from donors into an ethylenediaminetetraacetic acid (EDTA) tubes.
Whole blood experiment
Briefly, the initial number of erythrocytes was determined by pipetting 10 μL of blood and numbering using a cell counting glass system (Malassez cells). Since the cytotoxicity assays were performed with 400 μL of blood, the dilution factor (40) was systematically reported to ensure an accurate report of the number of lyses cells. 10-40 μL of fraction A and C were added to blood samples (to 400 μL). Samples were incubated for 45 minutes at 37°C. Observation and counting were performed under light microscope (40 ×).
Statistical analysis was done using the software Prism 4. Non-linear regression Analysis LOGEC 50 was used to compare extract haemolytic activity, a P value of P < 0.05 was considered as statistically significant.
Acute toxicity studies (in vivo assay)
Experiments were carried out according to the World Health Organization (WHO) guidelines on the evaluation of the medicinal plants cytotoxicity. The lethal dose (LD 50 ) was determined according to the Schorderet method (1992).th [ 8] Briefly, eight mice (22-30 g) divided into four groups were used to perform this experiment. Group one, two, three, and four received orally and respectively water (control), 50, 150, and 250 mg/mL of each of the fraction A. Mice were kept into the nursery for a month and the number of deaths among the different groups reported.
| Results|| |
To our knowledge, this is the first report on C. pruniforme phytochemical screening and cytotoxicity. Our investigations show that C. pruniforme is particularly rich in reducing sugars and phenolic compounds. The plant also contains flavonoids, saponins, and catechic tannins, [Table 1]. However, cytotoxicity study [Figure 2] showed that C. pruniforme extracts were hemolytic. C. pruniforme aqueous extracts showed hemolytic activities of 0%, 3%, 7%, 20%, 33%, and 47% for the concentrations of 1.25, 2.5, 3.75, 5, 7.5, and 10 mg/mL, respectively, whereas total phenolic extracts showed hemolytic activities of 7%, 79%, 99.6%, 99.9%, and 100% for the concentrations of 1.25, 2.5, 3.75, 5, 7.5, and 10 mg/mL, respectively. The hemolytic activity of total phenolic extracts was significantly high compared to the one of aqueous extracts (P < 0.0001) [Figure 2].
|Table 1: Phytochimical screening of aqueous and ethanolic extracts of C. pruniforme |
Click here to view
|Figure 2: Hemolytic activity of aqueous and phenolic extracts on human erythrocytes. Aqueous and phenolic extracts effect on human erythrocytes was assayed at six different concentrations: 1.25, 2.5, 3.75, 5, 7.5, and 10 mg/mL. Aqueous extract hemolytic activity started with the concentration of 2.5 mg/mL. At concentration 10 mg/ml, aqueous extract led to 47% of erythrocytes lyses. Phenolic extract hemolytic activity started with the concentration of 1.25mg/mL. At concentration 2.5 mg/ml, phenolic extracts achieved 79% erythrocytes lyses|
Click here to view
In vivo study, we see the death of two mice, 1 hour after the administration of 50 mg/mL of the aqueous extracts to the second group. The administration of 150 mg/mL to third group resulted in the death of six mice. 250 mg/mL killed all mice of the fourth group after 24 hour of treatment. This experience shows the toxic effects of C. pruniforme.
| Discussion|| |
Plants rich in flavonoids and tannins are used in traditional medicine for the treatment of microbial infections and as hemostatic agents.,,, Phytochimical screening shows that C. pruniforme bark is rich in phenols, flavonoids, tannins, and saponins. We can, therefore, suggest C. pruniforme as a potential herbal medicine.
Several studies have shown that saponins have hemolytic effects on the erythrocytes. ,, Our study shows that the aqueous extracts present hemolytic effect on human erythrocytes. This could be explained by the presence of saponins on C. pruniforme bark. However, the polyphenol compounds are not known to have hemolytic properties, we can extrapolate that total phenolic extracts contain more than polyphenols. They may also be associated with other plant components such as carbohydrates and proteins.  This would explain the observed hemolytic effect; these compounds could be probably associated with saponins. The reduced hemolytic activity of the aqueous extracts when compared to total phenolic extract, maybe to an extent, due to the protective effect of flavonoids which have been reported in literature to have antiviral, anti-allergic, anti-platelet, anti-inflammatory, antitumor, and antioxidant activities.  Another possible explanation of the differences observed may be the facts that compound in phenolic extract are concentrated.
The cytotoxic or toxic effects of C. pruniforme raise the security issue of C. pruniforme consumption. Population should be advised regarding the potentials risks (anemia and intoxication) of C. pruniforme consumption. In vivo studies on mice showed that the LD 50 was 90 mg/kg, which might suggest that this plant is probably toxic. As C. pruniforme shows hemolytic activities, we can suggest this plant as a potential candidate for the treatment of polyglobulies, hence, further investigation is required. In future studies, we will separate the acid phenolic and tannins from this plant. Identify the molecules and redo the same tests to confirm or reverse phenolic compounds that have effectively a hemolytic effect.
| Conclusion|| |
C. pruniforme shows a hemolytic effect on human erythrocytes. These effects are observed on the aqueous extracts and are more pronounced on the total phenolic extracts. As the empirical use of C. pruniforme might be to an extend detrimental for health, methods for safe use of its extracts, the plant possible side effect and associated symptoms should be determined and communicated to all the population.
| Acknowledgments|| |
Thanks to Dr. Nguema-Ona Eric and Bivigou Francis for their critical reading of the manuscript. Thanks to Raoul Niangadouma for identification and collect of this plant. Thanks also to J. A. Minlama Mintogho, E. C. Moussounda, and T. Ongouori Bissaka, for their technical assistance. S. A. A. is grateful to the Unity of Medical Research of the Hospital Albert Schweitzer of Lambaréné and the National Laboratory of Libreville in Gabon for their collaboration in this work.
| References|| |
|1.||Diallo D, Paulsen BS, Liljebäck TH, Michaelsen TE. The malian medicinal plant Trichilia emetica, studies on polysaccharides with complement fixing ability. J Ethnopharmacol 2003;84:279-87. |
|2.||Sakurai MH, Kiyohara H, Matsumuto T, Tsumuraya Y, Hashimoto Y, Yamada H. Characterization of antigenic epitopes in anti-ulcer pectic polysaccharides from Bupleurum falcatum L. using several carbohydrates. Carbohydr Res 1998;311:219-29. |
|3.||Aubréville A, Pellegrin F. Sapotaceae. Flore in Gabon. vol. 1. France: National Museum of Natural HistoryMuséum National d'Histoire Naturelle; 1961. p. 162. |
|4.||Dai J, Mumper RJ. Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties. Molecules 2010;15:7313-52. |
|5.||N'guessan K, Beugré K, Zirihi GN, Traoré D, Aké-Assi L. Phytochimical Screening of some plants used in traditional medicine in Krobou region (Agboville, Ivory Coast). Science Nature 2009;1:1-15. |
|6.||Lemmens RH. Chrysophyllum pruniforme Pierre ex Engl. from Protabase. In: Louppe D, Oteng-Amoako AA, Brink M, editors. 2007; PROTA (Plant Resources of Tropical Africa ), Wageningen, Netherlands. Available from: http://database.prota.org/search.htm. [15/02/2013]. |
|7.||Gholamreza DN, Fariba S, Effat B, Ehsan M, Vahid A. Medicinal plants as surface activity modifiers. J Med Plants Res 2011;5:5378-83. |
|8.||Rizk AM. Constituents of plants growing in Qatar. Fitoterapia 1982;52:35-2. |
|9.||Brain KR, Turner TD. The practical evaluation of phytopharmaceuticals. John Wright Editors, ISBN 0856080128, 9780856080128; 1975. p. 57-8. |
|10.||Schorderet M. Pharmacology: fundamental concepts and therapeutically applications. Frison-Roche-Slatkine Edition 3e, ISBN 2876712768, 9782876712768; 1992. p. 33-4. |
|11.||Longuefosse JL. Caraïbean medicinal plants. Gondwana Edition (Vol. 1), ISBN 2908490315, 9782908490312; 2003. p. 238-9. |
|12.||Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006;27:1-93. |
|13.||Capasso A, Piacente S, Pizza C, De Tommasi N, Jativa C, Sorrentino L. Isoquinoline alkaloids from Argemone mexicana reduce morphine with drawal in guinea pig isolated ileum. Planta Med 1997;63:326-8. |
|14.||Rajesh P, Latha S, Selvamani P, Rajesh VK. Phytochemical screening and toxicity studies on the leaves of Capparis sepiaria Linn. (Capparidaceae). J Basic Clin Pharm 2010;1:41-6. |
|15.||Santos WR, Bernardo RR, Peçanha LM, Palatnik M, Parente JP, Palatnik de Sousa CB. Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani. Vaccine 1999;15:1024-9. |
|16.||Francis G, Kerem Z, Makkar HP, Becker K. The biological action of saponins in animal systems: A review. Br J Nutr 2002;88:587-05. |
|17.||Mendel F. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res 2007;51:116-34. |
[Figure 1], [Figure 2]